Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (80705)	5/14/2000 10:45:00 PM
From: Alohal	Read Replies (1) \| Respond to of 132070

Mike, re DRMD: Do you continue to like DRMD even with the marketinf agreement with SOLVAY? siliconinvestor.com Looks to me like Solvay gets 80% of the profits from Cenestin until they have recovered all cost for promoting & marketing, then DRMD gets 80% until they have recovered their $38M it cost to develop the drug, then 50% each after that. In addition Solvay gets exclusive rights to Cenestin outside the US! This does not sound attractive to me. Any thoughts? Cheers Alohal